Skip to content

The Impact of Cerebrospinal Fluid Leakage on the Onset, Progression and Surgical Treatment of Chronic Subdural Hematoma: A Prospective Multicenter Cohort Study

The Impact of Cerebrospinal Fluid Leakage on the Onset, Progression and Surgical Treatment of Chronic Subdural Hematoma: A Prospective Multicenter Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120431
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-13
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Subdural Hematoma

Interventions

Observation group (divided into cerebrospinal fluid leakage group and non-cerebrospinal fluid leakage group based on whether cerebrospinal fluid flowed into the hematoma cavity):None

Sponsors

the Second Affiliated Hospital of Bengbu Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosed with chronic subdural hematoma (CSDH) and requiring surgical treatment (burr-hole drainage, endoscopic hematoma evacuation + drainage, or small bone window hematoma evacuation); 2.Aged over 18 years; 3.Modified Rankin Scale (mRS) score <= 2 previously; 4.The patient or authorized family member agrees to participate in this cohort study.

Exclusion criteria

Exclusion criteria: 1.Patients with hepatic insufficiency or failure: ALT or AST > 120 U/L; 2.Patients with renal insufficiency: Serum creatinine > 132 µmol/L; 3.Severe heart failure; 4.Patients who develop postoperative complications that significantly affect prognosis, such as acute epidural hematoma, acute subdural hematoma, intracerebral hemorrhage, cerebral infarction, or intracranial infection; 5.Patients with severe postoperative complications (severe pulmonary infection, pulmonary embolism, etc.) who are expected to die within 1 week; 6.Patients with CSDH caused by previous craniotomy or arachnoid cysts.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale score;

Secondary

MeasureTime frame
Glasgow Outcome Scale score;Postoperative recurrence rate;Postoperative rebleeding;Postoperative hematoma clearance rate;Brain tissue bulge rate at 1 week post-operation;

Countries

China

Contacts

Public ContactZhao Biao

the Second Affiliated Hospital of Bengbu Medical University

zhaobiao25@163.com+86 151 7854 7768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026